The evidence is mixed5 supporting, 4 against, 1 worth knowing
Supporting
matches growing fast, sold off anyway, which has beaten the market by +1.11 points over 20 sessions across 29,180 past signals
2 of the scans it matches have a positive measured record
4 independent kinds of evidence agree today, which is uncommon
revenue grew 34% year on year in the quarter ending 30 June 2026
net margin has widened from -10.4% to 1.3% across four quarters
Against
trading 22% below its 200-day average
at 1% of its 52-week range — nearly everyone who bought in the past year is underwater
down 50% over twelve months
1 of the scans it matches has historically underperformed the market
Worth knowing
RSI at 17 is washed out — historically the better half of this site's measured edge comes from exactly this condition
What would change this read: a close back above 241, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working2
Revenue rose 33.8% year on year, from Rs 662 cr to Rs 886 cr.
+33.8%Rs 662 crRs 886 cr
3 different kinds of evidence point at it tonight, not 3 versions of the same one.
3 families
Needs watching8
Net profit -48.4% year on year, Rs 23 cr to Rs 12 cr.
-48.4%Rs 23 crRs 12 cr
Profit grew slower than revenue, -48.4% against +33.8%.
-48.4%+33.8%
Net margin fell from 3.5% to 1.3% this quarter versus last year.
3.5%1.3%
Trading 21.8% below its 200-day average.
-21.8%
49% below its 52-week high.
-49%
Only 1.0% above its 52-week low.
+1.0%
Down 50.3% over the past year.
-50.3%
A warning rule fires on it tonight: near a 52-week low.
Near a 52-week low
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 2 of these 4 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
6 of 47 matched on 10 Sep
EPACK matches 6 of the 47 scans today, across 4 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
EPACK trades at 57× trailing earnings, below its median of 66× over this window — 14% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423) · Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · Results filings were typically -0.51pt vs the market over the next 5 sessions (n=7,726)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 34% against the same quarter a year earlier
net margin widened from 0.0% to 1.3%
revenue rose in 3 of the last 4 quarters
Going against it
profit dropped 48% year on year
the company has not been profitable over the last four filed quarters
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
886
20
12
1.23
1.3%
Q4 FY26
31 Mar · consolidated
591
3
0
0.00
0.0%
Q3 FY26
31 Dec · consolidated
428
7
3
0.27
0.6%
Q2 FY26
30 Sep · consolidated
213
-27
-22
—
-10.4%
Q1 FY26
30 Jun · consolidated
662
32
23
2.39
3.5%
Q4 FY25
31 Mar · consolidated
643
51
38
3.93
5.9%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-13.8%
Versus 200-day average-21.8%
Below 52-week high-49.3%
Above 52-week low+1.0%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)17.5
Higher closes in last 53 of 5
Six-month return−23.43%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)2.76%
Volume versus 20-day0.8x
Median daily turnoverRs 7.4 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.
Session
Scans
Which
8 Sep
1
Growing fast, sold off anyway
7 Sep
2
Near a 52-week low, Growing fast, sold off anyway
4 Sep
1
Growing fast, sold off anyway
3 Sep
1
Growing fast, sold off anyway
2 Sep
1
Growing fast, sold off anyway
31 Aug
2
Near a 52-week low, Growing fast, sold off anyway
28 Aug
3
Near a 52-week low, Falling on heavy volume, Growing fast, sold off anyway